Ashley Addiction Treatment Secures Million to Enhance Research and Expand Services
Ashley Addiction Treatment, a leading nonprofit provider in the field of substance use disorder (SUD) treatment, has successfully raised million as part of a larger million capital campaign. This initiative aims to bolster research efforts and extend programming for individuals seeking recovery from addiction.
The strategic campaign identifies four key objectives: the establishment of a new research facility, renovation and enhancement of existing infrastructures, the expansion of family programs, and the implementation of scholarship opportunities for treatment. These priorities underline Ashley’s commitment to advancing its mission of providing comprehensive and effective addiction treatment.
At the forefront of this initiative is the forthcoming Namvary Research Building, which is set to become a hub for cutting-edge research in addiction recovery. This facility will accommodate a dedicated team of researchers responsible for publishing innovative findings and converting those insights into evidence-based clinical protocols. “At Ashley, we have a strong research team that’s been advancing the science of recovery for years,” stated Dr. Greg Hobelmann, co-CEO and president of Ashley Addiction Treatment. “With a new research center, we’ll be able to build on that foundation, dig deeper into what truly works and share those insights more broadly.”
Founded in 1983 in Havre de Grace, Maryland, Ashley Addiction Treatment is renowned for its diverse service offerings, which include 117 inpatient treatment beds, outpatient programs, virtual care options, family support services, and a specialized men’s extended care program. For the fiscal year 2024, Ashley reported total revenues of approximately .3 million, reflecting its growing influence in the addiction treatment sector.
In an effort to broaden its healthcare reach, Ashley expanded its services to include virtual mental health support for all Maryland residents in early 2024, catering to individuals regardless of a formal SUD diagnosis. This move highlights the organization’s proactive approach toward addressing mental health needs in an increasingly digital world.
Moreover, Ashley Addiction Treatment is committed to integrating new technologies into its therapeutic practices. In a unique research collaboration with WHOOP, a company that specializes in wearable technology, Ashley aims to explore the potential applications of such innovations in addiction treatment.
Ashley is not alone in its commitment to research; other institutions such as Caron Treatment Centers, based in Wernersville, Pennsylvania, are also incorporating research into their therapeutic approaches, further invigorating the SUD treatment landscape.
As prominent entities like Ashley Addiction Treatment continue to invest in research and facility improvements, the overarching goal remains clear: to enhance the efficacy of addiction treatment and support the journey of recovery for countless individuals and their families.
